Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) vs TransMedics Group Inc (TMDX) Price & Performance

MONDELEZ INTERNATIONAL INC Common StockTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

MONDELEZ INTERNATIONAL INC Common Stock vs TransMedics Group Inc — how do they compare? MONDELEZ INTERNATIONAL INC Common Stock trades at $59.59 (market cap $77.37B), while TransMedics Group Inc trades at $75 (market cap $2.54B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 30.5× TransMedics Group Inc's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.32% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

MDLZTMDX
Market Cap
$77.37B$2.54B
Sector
Consumer StaplesTechnology
52-Week High
$70.75$150.42
52-Week Low
$51.51$61.99
Enterprise Value
$97.46B$2.94B
Dividend Yield
3.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MONDELEZ INTERNATIONAL INC Common Stock

Mondelez International (MDLZ) trades at $60.15, down 1.39% today, with a bullish technical signal supported by moving averages. The company maintains strong profitability with 28.77% gross margins and has beaten earnings estimates for three consecutive quarters. Recent corporate developments include a new CFO appointment and continued dividend payments, while analyst consensus remains strongly positive with a $68 price target representing 13% upside potential.

The outlook for MDLZ appears favorable with consistent earnings beats and solid dividend yield, though investors face risks from margin compression and commodity price volatility. Wall Street's bullish stance is supported by the company's market leadership in snacks and innovation pipeline, but execution on volume growth remains critical for sustained performance.

TransMedics Group Inc

TransMedics (TMDX) trades at $73.47, down 0.69% with neutral technical signals. The stock shows strong profitability with 27% net margins and 45% ROE, though Q1 2026 earnings missed expectations. Recent strategic investment in European aviation logistics aims to expand the Organ Care System platform. Analyst consensus remains bullish with a $108.71 price target representing 48% upside potential.

Long-term growth prospects appear solid given TMDX's expanding transplant ecosystem, but near-term margin pressure from expansion investments and execution risks warrant caution. The company maintains competitive advantages in organ transplant logistics, though increased spending and competitive threats from alternatives like Strata Critical Medical present headwinds for shareholder returns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MONDELEZ INTERNATIONAL INC Common Stock

Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.

Read more on MDLZ

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX